Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Name: Prothena Corporation plc: Is Infosys Ltd. worth buying?
Item: Prothena Corporation plc
Rating: 1.073611125
Author: Trendlyne DVM scores

Momentum Trap

about

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amy...

9.76 -0.10 (-1.01%)

New 52W High in past week

699.8K

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

17.7 / 100

Technically Neutral

46.0 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 119%

5 analysts

Prothena Corporation plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amy...

New 52W High in past week

SWOT Analysis

Prothena Corporation plc Live Price Chart